The company’s latest preview report projects a guarded rebound for biopharma, as investor confidence returns and M&A activity ...
The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma.
Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
News-Medical.Net on MSN
New CHEST guidelines offer evidence-based biologic selection for severe asthma
The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...
As soon as a New York City mayoral candidate wins election – and in most cases for several months before –the city’s political class and media corps eagerly anticipate news of who he will hire to ...
The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback